Letrozole and CDK 4/6 Inhibitor for ER Positive, HER2 Negative Breast Cancer in Postmenopausal Women
Clinical trial NCT01709370 · UNKNOWN
Trial details
- NCT number
- NCT01709370
- Sponsor
- Organisation for Oncology and Translational Research
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.